In this podcasts, we discuss an important recent meta-analysis study from the University of Rome on the relationship between pegvisomant, a drug used for the treatment of acromegaly, and glucose metabolism. Dr. Blevins also dives into a fascinating discussion about meta-analysis studies, their advantages, and limitations and, importantly, the need to be very cautious when reading the results. Like in any search, there is excellent information out there, but there is also copious amounts of trash.
© 2019 – 2021, Pituitary World News. All rights reserved.